ERCC2 and malignant colon neoplasm: We found a significant relationship between the XPD Lys751Gln allelic variant and OS for CRC patients, particularly for rectal cancer patients, whereas XRCC1 Arg399Gln Gln allele correlated with reduced OS in stage II/III colon cancer patients.